Document ID: chunk:federal_register_of_legislation:F2025C00158:clause:4_1:p76
Version: federal_register_of_legislation:F2025C00158
Segment Type: clause
Provision Reference: sch 4 cl 1 (pt 76/162)
Character Range: 15059891–15067112

fracture is defined as a 20% or greater reduction in height of the anterior or mid portion of a vertebral body relative to the posterior height of that body, or, a 20% or greater reduction in any of these heights compared to the vertebral body above or below the affected vertebral body.
C14264              P14264         CN14264          Apixaban                                             Deep vein thrombosis                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Compliance with Authority Required procedures - Streamlined Authority Code 14264
                                                                                                         Continuing treatment
                                                    Rivaroxaban                                          The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND
                                                                                                         Patient must have confirmed acute symptomatic deep vein thrombosis; AND
                                                                                                         Patient must not have symptomatic pulmonary embolism.
C14266              P14266         CN14266          Eplerenone                                           Heart failure with a left ventricular ejection fraction of 40% or less                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Compliance with Authority Required procedures - Streamlined Authority Code 14266
                                                                                                         The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND
                                                                                                         The condition must occur within 3 to 14 days following an acute myocardial infarction; AND
                                                                                                         The treatment must be commenced within 14 days of an acute myocardial infarction.
                                                                                                         The date of the acute myocardial infarction and the date of initiation of treatment with this drug must be documented in the patient's medical records when PBS-subsidised treatment is initiated
C14267              P14267         CN14267          Perindopril with indapamide                          Hypertension
                                                                                                         The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND
                                                                                                         The treatment must not be for the initiation of anti-hypertensive therapy; AND
                                                                                                         The condition must be inadequately controlled with an ACE inhibitor.  or
                                                                                                         The condition must be inadequately controlled with a thiazide-like diuretic.
C14270              P14270         CN14270          Carvedilol                                           Patients receiving this drug as a pharmaceutical benefit prior to 1 August 2002
                                                                                                         The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient.
C14272              P14272         CN14272          Amlodipine with valsartan and hydrochlorothiazide    Hypertension
                                                                                                         The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND
                                                    Olmesartan with amlodipine and hydrochlorothiazide   The treatment must not be for the initiation of anti-hypertensive therapy; AND
                                                                                                         The condition must be inadequately controlled with concomitant treatment with two of the following:
                                                                                                          an angiotensin II antagonist, a dihydropyridine calcium channel blocker or a thiazide diuretic.
C14274              P14274         CN14274          Raloxifene                                           Established post-menopausal osteoporosis                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Compliance with Authority Required procedures - Streamlined Authority Code 14274
                                                                                                         The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND
                                                                                                         Patient must have fracture due to minimal trauma; AND
                                                                                                         Patient must not receive concomitant treatment with any other PBS-subsidised